DocMorris AG (0RRB.L)
0RRB.L Stock Price Chart
Explore DocMorris AG interactive price chart. Choose custom timeframes to analyze 0RRB.L price movements and trends.
0RRB.L Company Profile
Discover essential business fundamentals and corporate details for DocMorris AG (0RRB.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Distribution
IPO Date
12 Sept 2017
Employees
1.45K
CEO
Walter Hess
Description
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products, as well as medicines management services. It also operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals under the Zur Rose, PromoFarma, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
0RRB.L Financial Timeline
Browse a chronological timeline of DocMorris AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 19 Aug 2026
Upcoming earnings on 11 Mar 2026
Earnings released on 19 Aug 2025
Revenue for the quarter reached CHF 261.00M , missing expectations by -13.40%.
Earnings released on 8 May 2025
EPS came in at -CHF 5.02 , while revenue for the quarter reached CHF 520.76M , beating expectations by +80.63%.
Earnings released on 15 Oct 2024
EPS came in at -CHF 3.22 falling short of the estimated -CHF 2.55 by -26.24%, while revenue for the quarter reached CHF 496.28M , missing expectations by -3.50%.
Earnings released on 21 Mar 2024
EPS came in at -CHF 5.04 falling short of the estimated -CHF 2.16 by -133.32%, while revenue for the quarter reached CHF 506.51M , missing expectations by -1.17%.
Earnings released on 30 Jun 2023
EPS came in at -CHF 4.65 falling short of the estimated -CHF 0.52 by -799.29%, while revenue for the quarter reached CHF 462.96M , missing expectations by -27.89%.
Earnings released on 31 Dec 2022
EPS came in at -CHF 7.59 falling short of the estimated -CHF 3.13 by -142.24%, while revenue for the quarter reached CHF 784.26M , missing expectations by -8.82%.
Earnings released on 30 Jun 2022
EPS came in at -CHF 8.29 falling short of the estimated -CHF 4.95 by -67.52%, while revenue for the quarter reached CHF 823.96M , missing expectations by -15.14%.
Dividend declared on 15 Mar 2022
A dividend of CHF 0.29 per share was announced, adjusted to CHF 0.29.
Earnings released on 31 Dec 2021
EPS came in at -CHF 15.37 falling short of the estimated -CHF 3.81 by -303.89%, while revenue for the quarter reached CHF 886.72M , missing expectations by -7.44%.
Earnings released on 30 Jun 2021
EPS came in at -CHF 8.03 falling short of the estimated -CHF 3.71 by -116.57%, while revenue for the quarter reached CHF 839.79M , beating expectations by +0.75%.
Earnings released on 31 Dec 2020
EPS came in at -CHF 8.70 , while revenue for the quarter reached CHF 778.93M , missing expectations by -9.32%.
0RRB.L Stock Performance
Access detailed 0RRB.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.